NCT03232658

Brief Summary

Obstructive sleep apnea (OSA) is a common nocturnal breathing disorder characterized by complete (apnea) and partial (hypopnea) breathing cessations during sleep. Currently, clinical diagnosis of OSA is based on the clinical symptoms, especially excessive daytime sleepiness, and apnea-hypopnea index (AHI) providing a limited overview of the breathing cessation event frequency during the night. Longer obstruction events and deeper desaturations have been suggested to be more harmful than shorter and shallower events and these individual characteristics are completely neglected by conventional and currently used AHI. The investigators have previously introduced novel diagnostic parameters incorporating the number, duration and morphology of individual obstruction events and shown that they improve the severity estimation of OSA compared to traditional measures. Even though, the novel diagnostic parameters have so far tackled some of shortcomings of AHI, they need to be refined to further increase the accuracy of the OSA severity estimation. It has been shown that age, body mass index (BMI) and sleeping position are strongly related to the severity OSA. However, it is not thoroughly studied whether the severity of individual obstruction events progress over time (the aging process) and which factors affect to this progression. It is known that OSA patients with similar AHI values, durations of individual breathing cessation events can differ significantly. Longer and deeper events are connected to increased mortality rate in patients with moderate or severe OSA and thus, could be considered to be more detrimental than shorter and shallower ones. However, it has not been thoroughly investigated whether in severe OSA patients with identical AHI values, sleep efficiency or hypertension is related to the severity of individual breathing cessation events. The investigators planned to explore, whether the individual breathing cessation event severity progress over time and how different confounding factors affect this progression. Furthermore, the correlation of EDS with the individual breathing cessation event severity, sleep structure, and frequency and occurrence of cortical arousals will be investigated. Also, the investigators will explore whether the percentage time of disturbed breathing from total sleep time is related to sleep efficiency or hypertension in severe OSA patients having similar AHI. Moreover, Positional therapy (PT) i.e., the avoidance of the supine posture during sleep is the treatment of choice for Positional Patients (PP) having most of their breathing abnormalities while sleeping supine. Since it is known that apneas/hypopneas are more severe while sleeping supine, this time the investigators will assess the therapeutic value of PT for severe Non Positional patients (NPP).

Trial Health

47
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2018

Typical duration for all trials

Geographic Reach
3 countries

4 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 25, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 28, 2017

Completed
7 months until next milestone

Study Start

First participant enrolled

March 1, 2018

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2020

Completed
Last Updated

February 28, 2019

Status Verified

February 1, 2019

Enrollment Period

2.8 years

First QC Date

July 25, 2017

Last Update Submit

February 26, 2019

Conditions

Outcome Measures

Primary Outcomes (5)

  • Severity of individual obstruction events over time.

    We will explore how the duration of individual apnea and hypopnea events and duration, depth and area of individual desaturation events progress over time.

    From the beginning until December 2019

  • Optimization of OSA severity definition.

    Optimization of the diagnostic parameters of OSA which incorporates the severity of individual breathing cessation events.

    January 2018 until December 2020

  • Effect of severity of individual obstruction events on excessive daytime sleepiness.

    We will investigate the correlation between the severity of individual breathing cessation events and excessive daytime sleepiness measured with objective means (i.e. Multiple Sleep Latency Test (MSLT) and Maintenance of Wakefulness Test (MWT))

    January 2018 until December 2019

  • Differences in severity of individual obstruction events between patients having severe OSA according to AHI.

    Severe OSA patients will be matched by AHI and the percentage time of disturbed breathing from total sleep time will be compared between these patients.

    From the beginning until December 2018

  • The assessment of the therapeutic value of Positional Therapy for severe Non Positional Patients (NPP)

    Positional therapy is an optimal therapeutic mode for PP but since the severity of apneas/hypopneas is worst in the supine than in the lateral posture, NPP could also obtain some benefits of this therapy we will assess the value of this possible benefit.

    From the beginning until December 2018

Eligibility Criteria

Age16 Years - 95 Years
Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

In-laboratory PSG recordings (n=7540) including EEG conducted and analysed at the Sleep Disorders Unit, Loewenstein Hospital - Rehabilitation Center for the patients with clinical suspicion of OSA will be studied.

You may qualify if:

  • Good technical quality of polysomnographic (PSG) records

You may not qualify if:

  • Bad technical quality of polysomnographic (PSG) records

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Sleep Disorders Centre, Department of Respiratory & Sleep Medicine, Princess Alexandra Hospital, Australia

Brisbane, Australia

ENROLLING BY INVITATION

Department of Applied Physics, University of Eastern Finland

Kuopio, Finland

ENROLLING BY INVITATION

Department of Clinical Neurophysiology, Seinäjoki Central Hospital,

Seinäjoki, Finland

ENROLLING BY INVITATION

Sleep Disorders Unit - Loewenstein Hospital

Raanana, 43100, Israel

RECRUITING

Related Publications (1)

  • Oksenberg A, Gadoth N, Toyras J, Leppanen T. Prevalence and characteristics of positional obstructive sleep apnea (POSA) in patients with severe OSA. Sleep Breath. 2020 Jun;24(2):551-559. doi: 10.1007/s11325-019-01897-1. Epub 2019 Jul 20.

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Study Officials

  • Arie Oksenberg, PhD

    Loewenstein Hospital - Rehabilitation Center, Raanana, Israel

    PRINCIPAL INVESTIGATOR
  • Juha Töyräs, PhD

    University of Eastern Finland

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Arie Oksenberg, PhD

CONTACT

Juha Töyräs, Professor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Arie Oksenberg, PhD- Director Sleep Disorders Unit

Study Record Dates

First Submitted

July 25, 2017

First Posted

July 28, 2017

Study Start

March 1, 2018

Primary Completion

December 1, 2020

Study Completion

December 1, 2020

Last Updated

February 28, 2019

Record last verified: 2019-02

Locations